Published in:
01-07-2016 | Editorial
Conversion therapy for gastric cancer: who can make conversion as successful as Goromaru?
Author:
Masanori Terashima
Published in:
Gastric Cancer
|
Issue 3/2016
Login to get access
Excerpt
Conversion therapy (surgery) is the case where the surgical resection is determined to be inapplicable to a tumor, and later, usually after the chemotherapy, surgical resection is performed. This practice is adopted to achieve a radical cure and therefore, differs from salvage surgery. To date, chemotherapy has had limited effects on gastrointestinal cancer, which is why, in most cases, resection after chemotherapy is performed as palliative treatment for stenosis, bleeding, and other complications. However, since the early 2000s, huge advances in chemotherapy have been made in the field of colorectal cancer, which was previously thought to be treatment resistant. Resection is now actively performed following chemotherapy, particularly in cases of liver metastasis [
1]. Conversion therapy is currently recognized as a significant factor for improving life expectancy in cases of advanced and recurrent colorectal cancer. …